Log In
person
Regeneron Pharmaceuticals Inc
REGN
summarize
7 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Bayer Collaboration Revenue |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
1.49B | 11.34% |
| Bio Rev |
Genetic, Genomic, and Sequencing Services for Life Science Research
These companies provide genetic, genomic, and sequencing services for life science research.
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| Other Collaboration Revenue |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
0.01B | 0.04% |
| Other Revenue |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
0.54B | 4.09% |
| Product Sales |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
7.08B | 53.96% |
| Roche Collaboration Revenue |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
0.21B | 1.61% |
| Sanofi Collaboration Revenue |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
3.8B | 28.97% |
| keyboard_arrow_down |
Bayer Collaboration Revenue
Pharmaceutical Patent Licensing
|
1.49B | 11.34% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Bio Rev
Genetic, Genomic, and Sequencing Services for Life Science Research
|
Non-Attributed |
Non-Attributed
help
Why Zero? Explanation of what the heck's going on here.
|
| keyboard_arrow_right |
help
Why Zero? Explanation of what the heck's going on here.
These companies provide genetic, genomic, and sequencing services for life science research.
|
||
| keyboard_arrow_down |
Other Collaboration Revenue
Pharmaceutical Patent Licensing
|
0.01B | 0.04% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Other Revenue
Pre-Revenue Pharmaceuticals
|
0.54B | 4.09% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||
| keyboard_arrow_down |
Product Sales
Branded Pharmaceuticals
|
7.08B | 53.96% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Roche Collaboration Revenue
Pharmaceutical Patent Licensing
|
0.21B | 1.61% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||
| keyboard_arrow_down |
Sanofi Collaboration Revenue
Pharmaceutical Patent Licensing
|
3.8B | 28.97% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||